勝捷企業(06090.HK):預計年度純利大幅增加不低於200%
格隆匯2月18日丨勝捷企業(06090.HK)公佈,與2020年同期公司權益持有人應占純利約1720萬新元比較,集團預期於截至2021年12月31日止年度錄得公司權益持有人應占純利大幅增加不低於200%。
該增加主要歸因於集團經營表現的改善:(i)自2020年第四季度起,集團於新加坡及馬來西亞的特建工人宿舍組合擴大;及(ii)集團於英國的特建學生公寓資產的入住率穩步回升,於2021財年下半年達到82%;以及由於就集團投資物業而言,相較於2020財年的公平估值虧損約2760萬新元,2021財年公平估值虧損約為310萬新元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.